Treatment of scopolamine-induced delirium.
D003693:Delirium / Q000139:chemically induced / Q000188:drug therapy*; D005260:Female; D006801:Humans; D010830:Physostigmine / Q000627:therapeutic use*; D012601:Scopolamine / Q000009:adverse effects*; D013405:Suicide
D010830:Physostigmine; D012601:Scopolamine